Results: 97

Tricobezoar: presentación de caso
Trichobezoar: presentation of case

Rev. cuba. reumatol; 21 (supl.1), 2019
Los tricobezoares pertenecen a la clasificación de los bezoares, tumores abdominales formados por el acumulo de diversas sustancias que pueden ocasionar la oclusión intestinal, se presenta un paciente, femenina, que acuda al médico por presentar dolor abdominal y vómitos, en el examen físico abdomin...

Methotrexate-induced mucositis with extra-mucosal involvement after acidental overdose

An. bras. dermatol; 93 (1), 2018

Impacto orçamentário para o Sistema Único de Saúde da incorporação do infliximabe biossimilar no tratamento de artrite reumatóide

A artrite reumatoide (AR) é uma doença inflamatória crônica, autoimune, que afeta as articulações, podendo produzir sintomas sistêmicos. O infliximabe é um medicamento biológico incorporado no Sistema Único de Saúde (SUS) para o tratamento da AR, que teve um biossimilar aprovado em 2015. Além...

Perfil clínico funcional de pacientes con artritis reumatoide derivados a Fisiatría en control en Centro Reumatólogico Avanzado (CREA) del Hospital Clínico Universidad de Chile
Functional clinical profile of patients with Rheumatoid arthritis derived to Physiatry in control at Centro Reumatólogico Avanzado (CREA) of Hospital Clínico Universidad de Chile

Rheumatoid arthritis (RA) is a systemic inflammatory disease that primarily affects the joints causing varying degrees of disability. Non-pharmacological management is increasing evidence of its usefulness impacting functionality. Objectives: To characterize the clinical / functional profile of patients ...

Treatment interruption of biological drugs and tofacitinib in rheumatoid arthritis: A systematic review of case reports

The aim of this study was to evaluate interruption of treatment with biological drugs and tofacitinib due to adverse events in patients with rheumatoid arthritis. A systematic review was performed in the electronic databases MEDLINE, Cochrane, Scopus, CRD, IPA, Lilacs and Scielo. Case reports addressing ...

Eficacia de medicamentos biológicos aprobados por ley 20850, para pacientes con artritis reumatoide refractaria a tratamiento

Rev. ANACEM (Impresa); 12 (2), 2018
INTRODUCCIÓN: La artritis reumatoide es una enfermedad crónica, sistémica, de origen autoinmune, caracterizada por compromiso articular simétrico. Dentro de su tratamiento destacan fármacos antirreumáticos, modificadores de la enfermedad, glucocorticoides y agentes biológicos. Estos últimos, han ...

Socioeconomic and therapy factor influence on self-reported fatigue, anxiety and depression in rheumatoid arthritis patients

Rev. bras. reumatol; 57 (6), 2017
Abstract Introduction: Fatigue, anxiety and depression are very frequent symptoms in patients with rheumatoid arthritis (RA). Goals: In this study we evaluated the influence of socioeconomic characteristics, therapy and comorbidities on the self-reported high fatigue, anxiety and depression in patients...

Three cases of anti-TNF induced myositis and literature review

Rev. bras. reumatol; 57 (6), 2017
Abstract Anti-tumor necrosis factor drugs are frequently preferred in the treatment of rheumatologic diseases and other inflammatory diseases. The development of myositis after using anti-tumor necrosis factor drugs is a rare clinical condition. Here we aimed to report cases who developed myositis after ...

Correlation between cellular expression of complement regulatory proteins with depletion and repopulation of B-lymphocytes in peripheral blood of patients with rheumatoid arthritis treated with rituximab

Rev. bras. reumatol; 57 (5), 2017
Abstract Objectives: To correlate the basal expression of complement regulatory proteins (CRPs) CD55, CD59, CD35, and CD46 in B-lymphocytes from the peripheral blood of a cohort of 10 patients with rheumatoid arthritis (RA) initiating treatment with rituximab (RTX) with depletion and time repopulation o...

Rheumatoid arthritis seems to have DMARD treatment decision influenced by fibromyalgia

Rev. bras. reumatol; 57 (5), 2017
Abstract Objective: To compare DMARD use in patients with and without FM over time, including overtreatment and undertreatment rates in both groups. Methods: A prospective cohort study with patients attending an RA outpatient clinic was conducted. Participants were consecutively recruited between March...